Shares of Chemomab Therapeutics to commence trading on the Nasdaq Capital Market on March 17, 2021 under the new ticker symbol "CMMB"...
Helping Create
Life Science Success Stories
SBI JI Innovation Funds invest in exceptional VC-backed life science companies with their feet on the ground and their heads in the stars.
Investing in
The Most Exciting Technologies
Cures for serious, early-onset rare diseases by combining the best of gene therapy and gene editing
With a track record of over 1,200 investments, we are committed to Israel through our local office, SBI JI Innovation. We have already invested in top-tier biotech startups with disruptive technologies.
We strive to create an ecosystem that serves as a bridge between Israel and Asia.
Recent News
Funding Extends Cash Runway through Multiple Expected Value Drivers Into 2023 Funds Expected to Support the Recently Announced...
Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement... Read More
Legal
Form 20-2 (Article 238-4, 238-5)
Public Inspection Regarding Specially Permitted Businesses for Qualified Institutional Investors, etc.
【FIEA Article 63(6)】
Date: 01/12/2020